Neurosurgical Review

, Volume 33, Issue 4, pp 451–456 | Cite as

Prognostic factors for long-term outcome of patients with surgical resection of skull base chordomas—106 cases review in one institution

  • Zhen Wu
  • Junting ZhangEmail author
  • Liwei Zhang
  • Guijun Jia
  • Jie Tang
  • Liang Wang
  • Zhongcheng Wang
Original Article


Skull base chordoma are still challenging. Between May 1993 and June 2005, 106 consecutive patients with skull base chordoma underwent surgical removal at Skull Base Division of Neurosurgery, Beijing Tiantan Hospital, China. Retrospective analysis included medical charts and images. The age of the patients ranged from 7 to 65 years old, with an average age of 35.6 years. Sixty patients were male; the other 46 were female (1.3:1). Follow up data were available in 79 cases ranging from 10 to 158 months (average 63.9 months) after operation. The prognostic factors for recurrence and survival were analyzed with Kaplan‐Meier, Cox regression and t‐test. Overall, 1, 3, 5 and 10 years survival rates were 87.2%, 79.4%, 67.6%and 59.5% respectively. One, 3, 5 and 10 year recurrent rates were 19.1%, 34.7%, 52.9% and 88.3%, respectively. The long term outcome of the skull base chordomas is poor. The previous radiotherapy or surgery, dedifferentiated pathology, and less tumor resection are risk factors for longterm survival and recurrence (p < 0.05). Although there is no statistic significant role of tumor adherent to vital structure for outcome (p = 0.051), it can not exclude its importance for favorable outcome. Gender, age, tumor size and staging are not independent risk factors for outcome. Surgical technique leading to radical tumor resection with less morbidity is advocatory and beneficial for patients with skull base chordoma with long term outcome, if the tumor could be exposed and resected completely, the recurrence rate was very low for most benign chordomas.


Chordoma Skull base Surgery Outcome Prognostic factor 



  1. 1.
    Akmal S, Ole SN, Anne GJ et al (1997) A retrospective clinicopathological study of 37 patients with chordoma: a Danish national series. Sarcoma 1:161–165CrossRefGoogle Scholar
  2. 2.
    Al-Mefty O, Borba LA (1997) Skull base chordoma: a management challenge. J Neurosurg 86:182–189CrossRefPubMedGoogle Scholar
  3. 3.
    Arnautovic KI, Al-Mefty O (2001) Surgical seeding of chordomas. J Neurosurg 95(5):798–803CrossRefPubMedGoogle Scholar
  4. 4.
    Benk V, Liebsch NJ, Munzenrider JE et al (1995) Base of skull and cervical spine chordomas in children treated by high-dose irradiation. Int J Radiat Oncol Biol Phys 31:577–581PubMedGoogle Scholar
  5. 5.
    Berven S, David Z, Henry JM et al (2002) Clinical outcome in chordoma: utility of flow cytometry in DNA determination. Spine 27:374–379CrossRefPubMedGoogle Scholar
  6. 6.
    Borba LA, Colli B, Al-Mefty O (2001) Skull base chordomas. Neurosurg Q 11:124–139CrossRefGoogle Scholar
  7. 7.
    Carstens PH (1995) Chordoid tumor a light, electron microscopic and immunohistochemical study. Ultrastruct Pathol 19:291–295CrossRefPubMedGoogle Scholar
  8. 8.
    Chugh R, Tawbi H, Lucas DR, Biermann JS, Schuetze SM, Baker LH (2007) Chordoma: the nonsarcoma primary bone tumor. Oncologist 12:1344–1350CrossRefPubMedGoogle Scholar
  9. 9.
    Colli B, Al-Mefty O (2001) Chordomas of the craniocervical junction: follow-up review and prognostic factors. J Neurosurg 95:933–943CrossRefPubMedGoogle Scholar
  10. 10.
    Crockard HA, Steel T, Plowman N et al (2001) A multidisciplinary approach to skull base chordomas. J Neurosurg 95:175–183CrossRefPubMedGoogle Scholar
  11. 11.
    Dorfman HD, Czerniak B (1995) Bone cancers. Cancer 75(1Suppl):203–210CrossRefPubMedGoogle Scholar
  12. 12.
    Forsyth PA, Cascino TL, Shaw EG et al (1993) Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg 78:741–747CrossRefPubMedGoogle Scholar
  13. 13.
    Gay E, SekharLN RE et al (1995) Chordomas and chondrosarcomas of the cranialbase: results and follow-up of 60 patients. Neurosurgery 36:87–896CrossRefGoogle Scholar
  14. 14.
    Kaneko Y, Sato Y, Iwaki T et al (1991) Chordoma in early childhood: a clinicopathological study. Neurosurgery 29:442CrossRefPubMedGoogle Scholar
  15. 15.
    Krayenbuhl H, Yasargil MG (1975) Cranial chordomas. Prog Neurol Surg 6:380–434Google Scholar
  16. 16.
    McMaster ML, Goldstein AM, Bromley CM et al (2001) Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control 12:1–11CrossRefPubMedGoogle Scholar
  17. 17.
    Mori K, Chano T, Kushima R (2002) Expression of E-cadherin in chordomas diagnostic marker and possible role of tumor cell affinity. Virchows Arch 440:123–127CrossRefPubMedGoogle Scholar
  18. 18.
    Mortini P, Mandelli C, Franzin A et al (2001) Surgical excision of clival tumors via the enlarged transcochlear approach. Indications and results. J Neurosurg Sci 45:127–139PubMedGoogle Scholar
  19. 19.
    Soo MY (2001) Chordoma: review of clinicoradiological features and factors affecting survival. Australas Radiol 45:427–434CrossRefPubMedGoogle Scholar
  20. 20.
    Thieblemont C, Biron P, Rocher F et al (1995) Prognostic factors in chordoma: role of postoperative radiotherapy. Eur J Cancer 31:2255–2259CrossRefGoogle Scholar
  21. 21.
    Tzortzidis F, Elahi F, Wright D et al (2006) Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery 59:230–237CrossRefPubMedGoogle Scholar
  22. 22.
    Vougioukas VI, Hubbe U, Schipper J et al (2003) Navigated transoral approach to the cranial base and the craniocervical junction: technical note. Neurosurgery 52:247–250CrossRefPubMedGoogle Scholar
  23. 23.
    Zhang JT, Wu Z, Jia GJ et al (2006) Microsurgical treatment of skull base chordoma. Chin J Neurosurg 22:29–31Google Scholar
  24. 24.
    Zhou DB, Yu XG, Xu BN et al (2005) Skull base chordoma. Chin J Neurosurg 21:156–159Google Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Zhen Wu
    • 1
  • Junting Zhang
    • 1
    Email author
  • Liwei Zhang
    • 1
  • Guijun Jia
    • 1
  • Jie Tang
    • 1
  • Liang Wang
    • 1
  • Zhongcheng Wang
    • 1
  1. 1.Skull Base and Brainstem Tumor Division, Department of Neurosurgery, Beijing Tiantan HospitalCapital Medical UniversityBeijingChina

Personalised recommendations